No Data
No Data
Prime Medicine Is Maintained at Buy by Chardan Capital
Prime Medicine Price Target Raised to $16 From $15 at Chardan
Why Prime Medicine Stock Is Soaring Today
Prime Medicine, Inc.: Promising Future in Gene Editing With Innovative AATD Program and Strategic Growth Potential
Prime Medicine Price Target Maintained With a $10.00/Share by HC Wainwright & Co.
JonesTrading Maintains Prime Medicine(PRME.US) With Buy Rating, Maintains Target Price $14
FergusonLeroy OP : down a few hun dun now
J L 7 2 : No matter what stock it is, usually when it rises to such a high level in one go, it will drop the next day, and this drop can continue for several days. Just be patient. When this stock rises above one yuan, it will take a long time to go back above two yuan. Good luck

.
FergusonLeroy OP : im in sunnova as well i like the potential
Saywallahcuzzy : tell me about it ..